PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Samsara Inc. (IOT)
33.600.80 (-2.33%)
33.44 - 34.57
31.40 - 61.90
7.61M / 5.87M (Avg.)
-152.73 | -0.22
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
15.17%
Revenue growth 1.25-1.5x CFLT's 10.52%. Bruce Berkowitz would check if differentiation or pricing power justifies outperformance.
17.03%
Gross profit growth 1.25-1.5x CFLT's 11.87%. Bruce Berkowitz would see if strategic sourcing or brand premium explains outperformance.
19.09%
Positive EBIT growth while CFLT is negative. John Neff might see a substantial edge in operational management.
19.09%
Positive operating income growth while CFLT is negative. John Neff might view this as a competitive edge in operations.
18.38%
Positive net income growth while CFLT is negative. John Neff might see a big relative performance advantage.
23.53%
Positive EPS growth while CFLT is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
23.53%
Positive diluted EPS growth while CFLT is negative. John Neff might view this as a strong relative advantage in controlling dilution.
5.82%
Share count expansion well above CFLT's 1.97%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
5.82%
Diluted share count expanding well above CFLT's 1.97%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
-20.97%
Negative OCF growth while CFLT is at 39.18%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-17.32%
Negative FCF growth while CFLT is at 36.82%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
8.16%
R&D growth drastically higher vs. CFLT's 11.81%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
1.66%
SG&A declining or stable vs. CFLT's 6.37%. David Dodd sees better overhead efficiency if it doesn't hamper revenue.